This website uses functional cookies, including analytical cookies.
The obtained statistical data cannot be traced back to individual users.
Additionally, you can choose to accept or refuse consent to use marketing cookies.
If you decline these additional cookies or refrain from making a choice, only functional cookies will be set.
See our cookie policy for more information.
Improving access to drugs: The critical role of supply chain risk
Improving access to drugs: The critical role of supply chain risk
Article based on research from five universities including RSM and the Norwegian Institute of Public Health: a simple way of thinking about medical criticality, supply chain risk and their interactions can lead to more sustainable solutions for drug shortages. Article references research by Harwin de Vries and Stef Lemmens.